CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands |
Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Treasury Stock |
Total |
| Balance at Mar. 31, 2016 |
$ 24
|
$ 853,288
|
$ (826,955)
|
$ (1,617)
|
$ 24,740
|
| Balance (in shares) at Mar. 31, 2016 |
23,857,516
|
|
|
103,643
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Purchase of treasury stock |
|
|
|
$ (22)
|
(22)
|
| Purchase of treasury stock (in shares) |
|
|
|
12,901
|
|
| Vested restricted stock awards (in shares) |
96,111
|
|
|
|
|
| Stock-based compensation |
|
706
|
|
|
706
|
| Exercise of stock options and employee stock purchases |
|
9
|
|
|
9
|
| Exercise of stock options and employee stock purchases (in shares) |
10,063
|
|
|
|
|
| Stock awards to Board of Directors |
|
104
|
|
|
104
|
| Stock awards to Board of Directors (in shares) |
65,167
|
|
|
|
|
| Issuance of common stock, net of issuance costs |
$ 15
|
20,590
|
|
|
20,605
|
| Issuance of common stock, net of issuance costs (in shares) |
14,891,317
|
|
|
|
|
| Net loss |
|
|
(25,244)
|
|
(25,244)
|
| Balance at Mar. 31, 2017 |
$ 39
|
874,697
|
(852,199)
|
$ (1,639)
|
20,898
|
| Balance (in shares) at Mar. 31, 2017 |
38,920,174
|
|
|
116,544
|
|
| Increase (Decrease) in Stockholders' Equity |
|
|
|
|
|
| Purchase of treasury stock |
|
|
|
$ (19)
|
(19)
|
| Purchase of treasury stock (in shares) |
|
|
|
29,408
|
|
| Vested restricted stock awards |
|
17
|
|
|
17
|
| Vested restricted stock awards (in shares) |
239,742
|
|
|
|
|
| Stock-based compensation |
|
586
|
|
|
586
|
| Exercise of stock options and employee stock purchases |
|
4
|
|
|
4
|
| Exercise of stock options and employee stock purchases (in shares) |
5,836
|
|
|
|
|
| Stock awards to Board of Directors |
|
(14)
|
|
|
(14)
|
| Stock awards to Board of Directors (in shares) |
3,969
|
|
|
|
|
| Issuance of common stock, net of issuance costs |
$ 16
|
11,820
|
|
|
$ 11,836
|
| Issuance of common stock, net of issuance costs (in shares) |
15,964,127
|
|
|
|
16,000,000
|
| Warrants exercised |
$ 2
|
1,734
|
|
|
$ 1,736
|
| Warrants exercised (in shares) |
1,928,750
|
|
|
|
|
| Change in warrants valuation |
|
741
|
|
|
741
|
| Net loss |
|
|
(10,026)
|
|
(10,026)
|
| Balance at Mar. 31, 2018 |
$ 57
|
$ 889,585
|
$ (862,225)
|
$ (1,658)
|
$ 25,759
|
| Balance (in shares) at Mar. 31, 2018 |
57,062,598
|
|
|
145,952
|
|